COLUMN INSIGHTS PLUS
Companies To Watch 12
Otonomy
To create new, FDA-approved
therapeutics this developer focuses
on novel delivery.
FEATURE
Building On
Biotech's Boom 34
An exclusive Q&A; with Aisling
Capital's Dennis Purcell
Patient-centric
Design 62
The next frontier in drug delivery
Capitol Perspectives 10
Outsourcing Insights 14
Rare Disease Know-how 50
Bio Innovation Notes 18
The Industry's Essential
Business Source
MARCH 2014
Expanding
The
Janssen
Legacy
Paul Stoffels crafts the pharmaceutical
company of the future at J&J; and Janssen p. 22
0 3 1 4 L S L c o v e r _ D G . i n d d 1 0314 LSL cover_DG.indd 1 2 / 1 9 / 2 0 1 4 2 : 0 0 : 5 0 P M 2/19/2014 2:00:50 PM